Article Type
Changed
Mon, 05/02/2022 - 09:38

At the conclusion of this activity, the participant will be able to:
• Appreciate the scope of the problem of Candida infection in terms of cost, lost productivity, and medical visits
• Learn current diagnostic and treatment patterns for vulvovaginal candidiasis
• Appreciate the attributes of the new antifungal class (triterpenoids) for vulvovaginal candidiasis
• Analyze clinical trial data with the non-azole approach to vulvovaginal candidiasis

Click here to read this supplement

To access post-test and evaluation, visit www.worldclasscme.com/online-courses/new-approach-old-problem-no-longer-just-azoles-candida

World Class CME designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category1 Credit™.

 

Sponsor
This supplement is supported by an educational grant from SCYNEXIS, Inc. It was…
Publications
Sections
Sponsor
This supplement is supported by an educational grant from SCYNEXIS, Inc. It was…
Sponsor
This supplement is supported by an educational grant from SCYNEXIS, Inc. It was…

At the conclusion of this activity, the participant will be able to:
• Appreciate the scope of the problem of Candida infection in terms of cost, lost productivity, and medical visits
• Learn current diagnostic and treatment patterns for vulvovaginal candidiasis
• Appreciate the attributes of the new antifungal class (triterpenoids) for vulvovaginal candidiasis
• Analyze clinical trial data with the non-azole approach to vulvovaginal candidiasis

Click here to read this supplement

To access post-test and evaluation, visit www.worldclasscme.com/online-courses/new-approach-old-problem-no-longer-just-azoles-candida

World Class CME designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category1 Credit™.

 

At the conclusion of this activity, the participant will be able to:
• Appreciate the scope of the problem of Candida infection in terms of cost, lost productivity, and medical visits
• Learn current diagnostic and treatment patterns for vulvovaginal candidiasis
• Appreciate the attributes of the new antifungal class (triterpenoids) for vulvovaginal candidiasis
• Analyze clinical trial data with the non-azole approach to vulvovaginal candidiasis

Click here to read this supplement

To access post-test and evaluation, visit www.worldclasscme.com/online-courses/new-approach-old-problem-no-longer-just-azoles-candida

World Class CME designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category1 Credit™.

 

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Information from Industry- Sponsored CME Supplement
Gate On Date
Wed, 02/23/2022 - 14:30
Un-Gate On Date
Wed, 02/23/2022 - 14:30
Use ProPublica
CFC Schedule Remove Status
Wed, 02/23/2022 - 14:30
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article